• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有DEK::AFF2融合的原发性喉鳞状细胞癌:首例病例报告

Primary Laryngeal Squamous Cell Carcinoma with DEK::AFF2 Fusion: The First Case Report.

作者信息

Huang Alan Yan-Lun, Kuo Ying-Ju, Yang Muh-Hwa, Tai Shyh-Kuan, Hang Jen-Fan

机构信息

Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd, Taipei City, 112201, Taiwan.

School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

出版信息

Head Neck Pathol. 2025 Apr 29;19(1):51. doi: 10.1007/s12105-025-01793-z.

DOI:10.1007/s12105-025-01793-z
PMID:40299135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12040765/
Abstract

BACKGROUND

DEK::AFF2 fusion squamous cell carcinoma (SCC) is a rare and aggressive subtype of non-keratinizing SCC. Previously reported cases have predominantly involved the sinonasal tract, middle ear, and skull base. To date, only 62 cases have been described, with rare exceptions including a primary lung tumor and a recurrent tumor in the trachea.

METHODS

We describe the first documented case of primary laryngeal SCC harboring a DEK::AFF2 fusion in a 64-year-old female who presented with progressive hoarseness and airway obstruction. Clinical, radiologic, histopathologic, immunohistochemical, and molecular analyses were performed to characterize the tumor.

RESULTS

Imaging and laryngoscopic evaluation revealed a transglottic mass. Histopathology demonstrated non-keratinizing SCC composed of monotonous tumor cells with an infiltrative growth pattern. Immunohistochemistry showed diffuse p40 positivity and moderate to strong nuclear AFF2 expression. The DEK::AFF2 fusion was confirmed by fluorescence in situ hybridization and reverse transcription polymerase chain reaction. The patient underwent total laryngectomy followed by adjuvant chemoradiotherapy and remains disease-free at 12 months of follow-up.

CONCLUSIONS

This case expands the known anatomical distribution of DEK::AFF2 fusion SCC to include the larynx, suggesting that this rare entity may arise throughout the respiratory tract epithelium. Recognition of this fusion is important in the differential diagnosis of non-keratinizing SCCs across the respiratory tract.

摘要

背景

DEK::AFF2融合性鳞状细胞癌(SCC)是一种罕见且侵袭性强的非角化性SCC亚型。先前报道的病例主要累及鼻窦、中耳和颅底。迄今为止,仅描述了62例,罕见的例外情况包括原发性肺肿瘤和气管复发性肿瘤。

方法

我们描述了首例记录在案的原发性喉SCC病例,该病例发生在一名64岁女性身上,表现为进行性声音嘶哑和气道阻塞。进行了临床、放射学、组织病理学、免疫组织化学和分子分析以对肿瘤进行特征描述。

结果

影像学和喉镜检查显示声门跨区肿物。组织病理学显示为非角化性SCC,由单一性肿瘤细胞组成,呈浸润性生长模式。免疫组织化学显示弥漫性p40阳性和中度至强核AFF2表达。通过荧光原位杂交和逆转录聚合酶链反应证实了DEK::AFF2融合。患者接受了全喉切除术,随后进行辅助放化疗,随访12个月时无疾病复发。

结论

该病例将已知的DEK::AFF2融合性SCC的解剖分布范围扩大至包括喉部,提示这种罕见实体可能出现在整个呼吸道上皮。认识到这种融合在呼吸道非角化性SCC的鉴别诊断中很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/12040765/ebb0b8ee66aa/12105_2025_1793_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/12040765/4c42996901fc/12105_2025_1793_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/12040765/ec5d1027d294/12105_2025_1793_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/12040765/fec44580a17d/12105_2025_1793_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/12040765/ebb0b8ee66aa/12105_2025_1793_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/12040765/4c42996901fc/12105_2025_1793_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/12040765/ec5d1027d294/12105_2025_1793_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/12040765/fec44580a17d/12105_2025_1793_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/12040765/ebb0b8ee66aa/12105_2025_1793_Fig4_HTML.jpg

相似文献

1
Primary Laryngeal Squamous Cell Carcinoma with DEK::AFF2 Fusion: The First Case Report.伴有DEK::AFF2融合的原发性喉鳞状细胞癌:首例病例报告
Head Neck Pathol. 2025 Apr 29;19(1):51. doi: 10.1007/s12105-025-01793-z.
2
DEK-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology.DEK-AFF2融合相关的鼻窦乳头状鳞状细胞癌:7例形态看似平淡的病例的临床病理特征
Mod Pathol. 2021 Oct;34(10):1820-1830. doi: 10.1038/s41379-021-00846-2. Epub 2021 Jun 9.
3
DEK::AFF2 Fusion-Associated Squamous Cell Carcinoma: A Case Series with Literature Review on an Emerging and Challenging Entity.DEK::AFF2 融合相关性鳞状细胞癌:一个新兴且极具挑战性实体的病例系列及文献回顾。
Head Neck Pathol. 2024 Sep 23;18(1):86. doi: 10.1007/s12105-024-01690-x.
4
DEK :: AFF2 Fusion Sinonasal and Skull Base Nonkeratinizing Squamous Cell Carcinoma : A Clinical Outcome Study Compared With Conventional Sinonasal Squamous Cell Carcinoma.DEK::AFF2融合性鼻窦和颅底非角化性鳞状细胞癌:与传统鼻窦鳞状细胞癌相比的临床结局研究
Am J Surg Pathol. 2025 Feb 1;49(2):130-137. doi: 10.1097/PAS.0000000000002335. Epub 2024 Dec 25.
5
DEK-AFF2 Carcinoma of the Sinonasal Region and Skull Base: Detailed Clinicopathologic Characterization of a Distinctive Entity.鼻窦和颅底的 DEK-AFF2 相关癌:一种独特实体的详细临床病理特征。
Am J Surg Pathol. 2021 Dec 1;45(12):1682-1693. doi: 10.1097/PAS.0000000000001741.
6
Middle Ear and Temporal Bone Nonkeratinizing Squamous Cell Carcinomas With DEK-AFF2 Fusion: An Emerging Entity.中耳和颞骨非角化性鳞状细胞癌伴 DEK-AFF2 融合:一种新兴实体。
Am J Surg Pathol. 2020 Sep;44(9):1244-1250. doi: 10.1097/PAS.0000000000001498.
7
Nuclear expression of AFF2 C-terminus is a sensitive and specific ancillary marker for DEK::AFF2 carcinoma of the sinonasal tract.核表达 AFF2 C 端是一种敏感且特异的辅助标志物,用于诊断发生于鼻窦的 DEK::AFF2 癌。
Mod Pathol. 2022 Nov;35(11):1587-1595. doi: 10.1038/s41379-022-01117-4. Epub 2022 Jun 14.
8
Sinonasal Squamous Cell Carcinoma with DEK::AFF2 Rearrangement : An Aggressive Cancer with Bland Morphology.具有 DEK::AFF2 重排的鼻腔鼻窦鳞状细胞癌:一种具有温和形态的侵袭性癌症。
Am J Surg Pathol. 2024 Nov 1;48(11):1408-1416. doi: 10.1097/PAS.0000000000002281. Epub 2024 Aug 12.
9
First Report of Thoracic Carcinoma With DEK::AFF2 Rearrangement: A Case Report.首例具有 DEK::AFF2 重排的胸腺癌:病例报告。
J Thorac Oncol. 2022 Aug;17(8):1050-1053. doi: 10.1016/j.jtho.2022.05.009. Epub 2022 Jun 28.
10
DEK::AFF2 Carcinoma of the Sinonasal Tract and Skull Base: A Comprehensive Review.鼻窦和颅底的 DEK::AFF2 相关癌:全面综述。
Surg Pathol Clin. 2024 Dec;17(4):587-597. doi: 10.1016/j.path.2024.07.008. Epub 2024 Aug 17.

本文引用的文献

1
Squamous Cell Carcinomas of the Sinonasal Region and Temporal Bone Diagnosed After Recurrences: A Report of Two Patients.复发后诊断出的鼻窦区域和颞骨鳞状细胞癌:两例病例报告
Int J Surg Pathol. 2025 Jan 17:10668969241301061. doi: 10.1177/10668969241301061.
2
DEK::AFF2 fusion-associated middle ear non-keratinizing squamous cell carcinoma: A case report.DEK::AFF2融合相关的中耳非角化鳞状细胞癌:一例报告。
World J Clin Oncol. 2024 Dec 24;15(12):1501-1506. doi: 10.5306/wjco.v15.i12.1501.
3
DEK :: AFF2 Fusion Sinonasal and Skull Base Nonkeratinizing Squamous Cell Carcinoma : A Clinical Outcome Study Compared With Conventional Sinonasal Squamous Cell Carcinoma.
DEK::AFF2融合性鼻窦和颅底非角化性鳞状细胞癌:与传统鼻窦鳞状细胞癌相比的临床结局研究
Am J Surg Pathol. 2025 Feb 1;49(2):130-137. doi: 10.1097/PAS.0000000000002335. Epub 2024 Dec 25.
4
Recurrent DEK::AFF2 fusion squamous cell carcinoma: prompts for diagnosis of this emerging distinct entity.复发性DEK::AFF2融合鳞状细胞癌:对这种新出现的独特实体的诊断提示。
Pathology. 2025 Feb;57(1):131-134. doi: 10.1016/j.pathol.2024.07.007. Epub 2024 Sep 30.
5
DEK::AFF2 Carcinoma of the Sinonasal Tract and Skull Base: A Comprehensive Review.鼻窦和颅底的 DEK::AFF2 相关癌:全面综述。
Surg Pathol Clin. 2024 Dec;17(4):587-597. doi: 10.1016/j.path.2024.07.008. Epub 2024 Aug 17.
6
DEK::AFF2 Fusion-Associated Squamous Cell Carcinoma: A Case Series with Literature Review on an Emerging and Challenging Entity.DEK::AFF2 融合相关性鳞状细胞癌:一个新兴且极具挑战性实体的病例系列及文献回顾。
Head Neck Pathol. 2024 Sep 23;18(1):86. doi: 10.1007/s12105-024-01690-x.
7
Sinonasal Squamous Cell Carcinoma with DEK::AFF2 Rearrangement : An Aggressive Cancer with Bland Morphology.具有 DEK::AFF2 重排的鼻腔鼻窦鳞状细胞癌:一种具有温和形态的侵袭性癌症。
Am J Surg Pathol. 2024 Nov 1;48(11):1408-1416. doi: 10.1097/PAS.0000000000002281. Epub 2024 Aug 12.
8
Diffuse p16 Expression is Against the Diagnosis of Carcinoma.弥漫性p16表达不利于癌的诊断。
Indian J Otolaryngol Head Neck Surg. 2024 Jun;76(3):2727-2728. doi: 10.1007/s12070-024-04564-4. Epub 2024 Mar 25.
9
Molecularly defined sinonasal malignancies: an overview with focus on the current WHO classification and recently described provisional entities.分子定义的鼻-鼻窦恶性肿瘤:概述,重点介绍当前的世界卫生组织分类和最近描述的暂定实体。
Virchows Arch. 2024 Jun;484(6):885-900. doi: 10.1007/s00428-024-03775-y. Epub 2024 Mar 16.
10
Re-evaluating a historic cohort of sinonasal and skull base mucoepidermoid carcinoma: an institutional experience.重新评估一组历史性的鼻腔鼻窦和颅底黏液表皮样癌病例:一项机构经验。
Diagn Pathol. 2024 Mar 1;19(1):46. doi: 10.1186/s13000-024-01466-5.